Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling

In addition to its known actions as a non-selective cyclooxygenase (COX) 1 and 2 inhibitor, we hypothesized that indomethacin can act as an allosteric modulator of the type 1 cannabinoid receptor (CB1R) because of its shared structural features with the known allosteric modulators of CB1R. Indometha...

Descripción completa

Detalles Bibliográficos
Autores principales: Laprairie, Robert B., Mohamed, Kawthar A., Zagzoog, Ayat, Kelly, Melanie E. M., Stevenson, Lesley A., Pertwee, Roger, Denovan-Wright, Eileen M., Thakur, Ganesh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813218/
https://www.ncbi.nlm.nih.gov/pubmed/31680861
http://dx.doi.org/10.3389/fnmol.2019.00257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813218/
https://www.ncbi.nlm.nih.gov/pubmed/31680861
http://dx.doi.org/10.3389/fnmol.2019.00257

Ejemplares similares